Cytopia zeroes in on brain
17 November, 2008 by Kate McDonaldCytopia commences efficacy trial dosing for VDA in brain cancer
Asian flu study a MARVEL
17 November, 2008 by Kate McDonaldBiota’s next-generation flu treatment moves into Phase III
Strains and sprains for Phosphagenics
17 November, 2008 by Kate McDonaldPhosphagenics opens Phase I trial of topical NSAID for inflammation
Biotech briefs
14 November, 2008 by Kate McDonaldPhosphagenics, Patrys, Novogen, Stem Cell Sciences, Mesoblast
Arana reports strong cash position
12 November, 2008 by Staff WritersArana reports $181m cash, announces acting CEO
Cash for proof of concept
11 November, 2008 by Kate McDonaldProstate cancer diagnostic and phages for chooks win grants
Cotton steps for Hexima
10 November, 2008 by Staff WritersHexima signs project with CSIRO for fungal resistance in cotton
Anadis in Merck Phase IV study
23 October, 2008 by Staff WritersAnadis’ oral therapy in combination with Merck anti-AIDS drug in Phase IV trial
Evado launches into Asia
22 October, 2008 by Staff WritersAustralian-designed clinical trial software launched in Malaysia and Singapore
Patent for BioProspect
20 October, 2008 by Staff WritersPatent a step closer to commercialisation for BioProspect
Peplin completes Neosil buy
20 October, 2008 by Staff WritersPeplin finalises purchase of Neosil, approves private placement
AusBiotech’s bioeconomy building
20 October, 2008 by Kate McDonaldThe AusBiotech conference begins in Melbourne this Sunday. We talk to AusBiotech CEO Dr Anna Lavelle about building a bioeconomy.
Inside the head of the fishapod
16 October, 2008 by Kate McDonaldMore details of the internal head skeleton of Tiktaalik roseae revealed
Silent suppression for Antisense
15 October, 2008 by Dylan Bushell-EmblingATL1101 suppresses prostate tumour growth in animal models
